- Gastric and duodenal ulcer
- NSAID-associated duodenal and gastric ulcer
- As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
- Gastro-esophageal reflux disease
- Long-term management of acid reflux disease
- Acid-related dyspepsia
- Severe ulcerating reflux esophagitis
- Prophylaxis of acid aspiration during general anesthesia
- Zollinger-Ellison syndrome
- Helicobacter pylori-induced peptic ulcer.
Related products
-35%
Omeprazole
-40%
Alco Pharmaceuticals Ltd.
-48%
Astra Biopharmaceuticals Ltd.
-58%
Decent Pharma Laboratories Ltd.
-73%
Omeprazole
-12%
Omeprazole
-34%
Ambee Pharmaceuticals Ltd.
-18%
ACI Pharmaceuticals Ltd